Investigation of benzene oxide in bone marrow and other tissues of F344 rats following metabolism of benzene in vitro and in vivo

Chemico-Biological Interactions

Volumn 122, Issue 1, 1999, Pages 41-58

  Lindstrom, Andrew B ^a,b   Yeowell O'Connell, Karen ^a   Waidyanatha, Suramya ^a   McDonald, Thomas A ^a   Rappaport, Stephen M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Benzene oxide; Bone marrow; Zymbal glands

Indexed keywords

BENZENE; PHENOL;

ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY MICROSOME; LIVER MICROSOME; MALE; METABOLITE; NONHUMAN; PROTEIN BINDING; RAT; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ANIMALS; BENZENE; BONE MARROW; CYCLOHEXANES; PHENOL; RATS; RATS, INBRED F344;

EID: 0032854809     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00104-0     Document Type: Article

References (49)

1. International Agency for Research on Cancer IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: some industrial chemicals and dyestuffs, 29, 1982, IARC, Lyon.
2. 1. NIH Publication No. 86-2545, 1986, National Toxicology Program, Research Triangle Park, NC.
3. 1 mice. Environ. Health Perspect. 82:1989;125-163.
4. Maltoni C., Ciliberti A., Cotti C., Conti B., Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ. Health Perspect. 82:1989;109-124.
5. Sammett D., Lee E.W., Kocsis J.J., Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health. 5:1979;785-792.
6. Irons R.D., Dent J.G., Baker T.S., Rickert D.E. Benzene is metabolized and covalently bound in bone marrow in situ. Chem. Biol. Interact. 30:1980;241-245.
7. Schnier G.G., Laethem C.L., Koop D.R. Identification and induction of cytochromes P450, P450IIE1 and P450IA1 in rabbit bone marrow. J. Pharmacol. Exp. Ther. 251:1989;790-796.
8. Gollmer L., Graf H., Ullrich V. Characterization of the benzene monooxygenase system in rabbit bone marrow. Biochem. Pharmacol. 33:1984;3597-3602.
9. Snyder R., Hedli C.C. An overview of benzene metabolism. Environ. Health Perspect. 104:1996;1165-1171.
10. Smith M.T., Yager J.W., Steinmetz K.L., Eastmond D.A. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 82:1989;23-29.
11. D. Ross, D. Siegel, D.G. Schattenberg, X.M. Sun, J.L. Moran, Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and potential role for modulation of apoptosis in benzene toxicity, Environ. Health Perspect. (1996) 1177-1182.
12. Gad-El-Karim M.M., Ramanujam V.M.S., Ahmed A.E., Legator M.S. Benzene myeloclastogenicity: a function of its metabolism. Am. J. Ind. Med. 7:1985;475-484.
13. Eastmond D.A., Smith M.T., Irons R.D. An interaction on benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 91:1987;85-95.
14. Henschler D., Eder E., Epe B., Schiffmann D. Genotoxic and cell-transformation properties of trans,trans-muconaldehyde. Mut. Res. 248:1991;35-43.
15. Witz G., Rao G., Goldstein B.D. Short-term toxicity of trans-trans-muconaldeyde. Toxicol. Appl. Pharmacol. 80:1985;511-516.
16. Snyder R., Dimitriadis E., Guy R., Hu P., Cooper K., Bauer H., Witz G., Goldstein B.D. Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 82:1989;31-35.
17. Jenna D.M., Daly J.W., Witkop B., Zaltzman-Nirenberg P., Underfriend S. Role of the arene oxide-oxepin system in the metabolism of aromatic substances. I. In vitro conversion of benzene oxide to a premercapturic acid and dihydrodiol. Arch. Biochem. Biophys. 128:1968;176-193.
18. Conney A.H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42:1982;4875-4912.
19. Kinoshita T., Santella R., Pulkrabek P., Jeffery A.M. Benzene oxide: genetic toxicity. Mut. Res. 91:1981;99-102.
20. Stark A.-A., Rastetter W.H. Structure-activity relationships in the mutagenicity and cytotoxicity of putative metabolites and related analogs of benzene derived from the valence tautomers benzene oxide and oxepin. Environ. Mol. Mutagenesis. 28:1996;284-293.
21. Busby W.F., Wang J., Stevens E.K., Padykula R.E., Aleksejczyk R.A., Berchtold G.A. Lung tumorigenicity of benzene oxide, benzene dihydrodiols and benzene diolepoxides in the BLU:Ha newborn mouse assay. Carcinogenesis. 11:1990;1473-1478.
22. Tunek A., Platt K., Bently P., Oesch F. Microsomal metabolism of benzene to species irreversibly binding to microsomal protein and the effects of modification of this metabolism. Mol. Pharmacol. 14:1978;920-929.
23. Lovem M.R., Tumer M.J., Myer M., Kedderis G.L., Bechtold W.E., Schlosser P.M. Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes. Carcinogenesis. 18:1997;1695-1700.
24. Müller G., Koelbl M., Hegar M. Urinary S-phenylmercapturic acid and phenylguanine as indicators of benzene exposure. Ho M.H., Dillion H.K. Biological Monitoring of Exposure to Chemicals: Organic Compounds. 1987;91-98 Wiley, New York.
25. Bechtold W.E., Sun J.D., Birnbaum L.S., Yin S.N., Li G.L., Kasicki S., Lucier G., Henderson R.F. S-Phenylcysteine formation in hemoglobin as a biological exposure index to benzene. Arch. Toxicol. 66:1992;303-309.
26. Bechtold W.E., Willis J.K., Sun J.D., Griffith W.C., Reddy T.V. Biological markers of exposure to benzene: S-phenylcysteine in albumin. Carcinogenesis. 13:1992;1217-1220.
27. 6]benzene. Cancer Res. 54:1994;4907-4914.
28. Yeowell-O'Connell K., Rothman N., Smith M.T., Hayes R.B., Li G., Waidyanatha S., Dosemeci M., Zhang L., Yin S., Titenko-Holiand N., Rappaport S.M. Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene. Carcinogenesis. 9:1998;1565-1571.
29. Lindstrom A.B., Yeowell-O'Connell K., Waidyanatha S., Tornero-Velez R., Golding B.T., Rappaport S.M. Measurement of benzene oxide in the blood of rats following administration of benzene. Carcinogenesis. 18:1997;1637-1641.
30. Lindstrom A.B., Yeowell-O'Connell K., Waidyanatha S., McDonald T.A., Golding B.T., Rappaport S.M. Formation of hemoglobin and albumin adducts of benzene oxide in mouse, rat, and human blood. Chem. Res. Toxicol. 11:1998;302-310.
31. Gillard J.R., Newlands M.J., Bridson J.N., Bumell D.J. Pi-Facial stereoselectivity in the Diels-Alder reactions of benzene oxides. Can. J. Chem. 69:1991;1337-1343.
32. Johansson I., Ingelman-Sundberg M. Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P450 (IIE1) in rat and rabbit liver microsomes. Cancer Res. 48:1988;5387-5390.
33. Johansson I., Ekstrom G., Scholte B., Puzycki D., Jornvall H., Ingelman-Sundberg M. Ethanol-, fasting-, and acetone-inducible cytochromes P-450 in rat liver: regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry. 27:1988;1925-1934.
34. Yeowell-O'Connell K., McDonaid T.A., Rappaport S.M. Analysis of hemoglobin adducts of benzene oxide by gas chromatography-mass spectrometry. Anal. Biochem. 237:1996;49-55.
35. Ehrenberg L., Hussain S. Genetic toxicity of some important epoxides. Mut. Res. 86:1981;1-113.
36. Osterman-Golkar S., Christakopoulus A., Segerback D., Hallstrom I. Evaluation of genetic risks of alkylating agents II. Hemoglobin as a dose monitor. Mut. Res. 34:1976;1-10.
37. Bethea R.M., Duran B.S., Boullion T.L. Statistical inference: hypothesis testing. Owen D.B. Statistical Methods for Engineers and Scientists. 1975;186 Marcel Dekker, New York, NY.
38. Low L.K., Lambert C.E., Meeks J.R., Naro P.A., Mackerer C.R. Tissue-specific metabolism of benzene in Zymbal gland and other solid tumor target tissues in rats. J. Am. Coll. Toxicol. 14:1995;40-60.
39. Johansson I., Ingelman-Sundberg M. Hydroxyl radical-mediated metabolic activation of benzene in microsomes and reconstituted enzyme system from rabbit liver. J. Biol. Chem. 258:1983;7311-7316.
40. Dresner J.H., Ibrahim N.G., Levere R.D. Presence and induction of drug metabolizing enzymes in rat bone marrow. Res. Commun. Chem. Pathol. and Pharmacol. 32:1981;281-298.
41. Pohl R.J., Fouts J.R. Cytochrome P-450-dependent xenobiotic metabolizing activity in Zymbal's gland, a specialized sebaceous gland in rodents. Cancer Res. 43:1983;3660-3662.
42. Genter M.B., Recio L. Absence of detectable P450 2E1 in bone marrow of B6C3F1 mice: relevance to butadiene-induced bone marrow toxicity. Fund. Appl. Toxicol. 22:1994;469-473.
43. Abraham N.G., Feidman E., Falck J.R., Lutton J.D., Schwartzman M.L. Modulation of erythropoiesis by novel human bone marrow cytochrome P450-dependent metabolites of arachidonic acid. Blood. 78:1991;1461-1466.
44. McCord A., Boyle S.P., Knowler J.T., Bumett A.K., Craft J.A. Metabolism of benz[a]anthracene by human bone marrow in vitro. Chem. Biol. Interact. 99:1996;29-40.
45. Schlosser P.M., Bond J.A., Medinsky M. Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis. 14:1993;2477-2486.
46. Porter T.D., Khani S.C., Coon M.J. Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes. Mol. Pharmacol. 36:1989;61-65.
47. Ronis M.J., Huang J., Longo V., Tindberg N., Ingelman-Sundberg M., Badger T.M. Expression and distribution of cytochrome P450 enzymes in male rat kidney: effects of ethanol, acetone and dietary conditions. Biochem. Pharmacol. 55:1998;123-129.
48. Amet Y., Berthou F., Fournier G., Dreano Y., Barbou L., Cledes J., Menez J.-F. Cytochrome P450 4A and 2E1 expression in human kidney microsomes. Biochem. Pharmacol. 53:1997;765-771.
49. Shim S.S. Physiology of blood circulation in bone. J. Bone Jt. Surg. 50A:1968;812.